Report

Global Inhalers and Nebulizers Market Size study, by Product (Inhalers and Nebulizers), by Indication (Asthma and COPD), by Distribution Mode (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies) and Regional Forecasts 2021-2027

  • Publish Date: Mar,2022
  • Report ID: QI037
  • Page : 250
  • Report Type : PDF (Email)
Global Inhalers and Nebulizers Market to reach USD xx billion by 2027.Global Inhalers and Nebulizers Market is valued approximately at USD xx Billion in 2020 and is anticipated to grow with a healthy growth rate of more than xx% over the forecast period 2021-2027. Inhalers and Nebulizers are the medical devices used in the treatment of respiratory illness, such as asthma, and COPD. The global Inhalers and Nebulizers market is being driven by rising prevalence of respiratory diseases for which these devices are needed to get relief from the illness. According to World Health Organization, in 2019, asthma affected around 262 million people and caused 4,61,000 deaths around the world. Also, Chronic Obstructive Pulmonary Disease (COPD) caused 3.23 million deaths in 2019 and is considered as the third leading cause of death globally. Another important driving factor is the increasing healthcare expenditure in developed countries such as U.S. and U.K. For instance, according to Statista, U.S. national health expenditure as percentage of GDP is projected to reach 19.7% by 2028 from 18.2% in 2021. Also, according to Statista, total healthcare expenditure in the United Kingdom has increased from USD 280.52 billion in 2017 to USD 311.35 billion in 2019. Furthermore, the increasing number of smokers, growing air pollution which affects human lungs, technological advancements and high adoption of these products due to their convenience and effectiveness, these factors will provide new opportunities for the global Inhalers and Nebulizers industry. For instance, according to Statista, the number of tobacco smokers among 15 years and older in South-East Asian region is projected to increase from 238 million in 2020 to 240 million by 2025.
However, accessibilities of substitutes and prevalence of certain side effects may impede market growth over the forecast period of 2021-2027.

The regional analysis for the global Inhalers and Nebulizers Market is based on the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading region across the world in terms of market share due to continuous innovations in technology and high burden of respiratory diseases along with growing geriatric population in the region. Whereas Asia-Pacific is anticipated to exhibit the highest CAGR over the forecast period 2021-2027 due to rising personal disposable income, rising prevalence of diseases, supportive government initiatives and increase in the healthcare expenses in the region.

Major market player included in this report are:
3M
Beurer GmbH
Boehringer Ingelheim International GmbH.
Cohero Health, Inc.
DeVilbiss Healthcare LLC
Dr Trust
Glenmark Pharmaceuticals
Haiden Technology Pvt. Ltd.
Koninklijke Philips N.V.
Novartis AG

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product:
Inhalers
Nebulizers
By Indication:
Asthma
COPD
By Distribution Mode:
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.

Target Audience of the Global Inhalers and Nebulizers Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors